Legal & General Group PLC Dyne Therapeutics, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 68,465 shares of DYN stock, worth $783,924. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,465

Previous 111,657 38.68%

Holding current value

$783,924

Previous $4.01 Million 59.78%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$23.56 - $35.55 $1.02 Million - $1.54 Million	-43,192 Reduced 38.68%	68,465 $1.61 Million
Q3 2024 Feb 28, 2025	BUY	$31.94 - $47.04 $1.21 Million - $1.79 Million	37,982 Added 55.48%	106,447 $3.82 Million
Q3 2024 Nov 14, 2024	BUY	$31.94 - $47.04 $1.47 Million - $2.17 Million	46,113 Added 70.35%	111,657 $4.01 Million
Q2 2024 Aug 14, 2024	BUY	$23.65 - $35.63 $507,126 - $764,014	21,443 Added 48.62%	65,544 $2.31 Million
Q1 2024 May 14, 2024	BUY	$13.06 - $29.18 $258,940 - $578,551	19,827 Added 81.68%	44,101 $1.25 Million
Q4 2023 Feb 15, 2024	BUY	$6.62 - $13.64 $1,204 - $2,482	182 Added 0.76%	24,274 $322,000
Q3 2023 Nov 14, 2023	SELL	$8.6 - $12.18 $3,508 - $4,969	-408 Reduced 1.67%	24,092 $215,000
Q2 2023 Aug 14, 2023	BUY	$8.53 - $14.28 $117,679 - $197,006	13,796 Added 128.89%	24,500 $275,000
Q1 2023 May 15, 2023	BUY	$10.88 - $15.0 $3,068 - $4,230	282 Added 2.71%	10,704 $123,000
Q3 2022 Nov 14, 2022	SELL	$7.2 - $15.17 $16,812 - $35,421	-2,335 Reduced 18.3%	10,422 $133,000
Q2 2022 Aug 22, 2022	BUY	$4.36 - $10.5 $20,836 - $50,179	4,779 Added 59.9%	12,757 $88,000
Q3 2021 Nov 15, 2021	BUY	$15.6 - $21.46 $71,401 - $98,222	4,577 Added 134.58%	7,978 $129,000
Q2 2021 Aug 12, 2021	BUY	$15.94 - $22.33 $26,858 - $37,626	1,685 Added 98.19%	3,401 $71,000
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $3,346 - $7,002	239 Added 16.18%	1,716 $27,000
Q4 2020 Feb 12, 2021	BUY	$16.81 - $23.94 $16,507 - $23,509	982 Added 198.38%	1,477 $31,000
Q3 2020 Nov 13, 2020	BUY	$20.0 - $23.9 $9,900 - $11,830	495 New	495 $10,000

Others Institutions Holding DYN

# of Institutions

212

Shares Held

103M

Call Options Held

135K

Put Options Held

435K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $593M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Dyne Therapeutics, Inc. Transaction History